The global market for PCSK9 Cholesterol-Lowering Drugs was valued at US$ 1573 million in the year 2024 and is projected to reach a revised size of US$ 2190 million by 2031, growing at a CAGR of 5.6% during the forecast period.

PCSK9 Cholesterol-Lowering Drugs Market

PCSK9 Cholesterol-Lowering Drugs are inhibitors targeting PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), a protein expressed in the liver that promotes the degradation of low-density lipoprotein (LDL) receptors by binding to them, thereby reducing the clearance of LDL cholesterol by the liver. PCSK9 inhibitors work by inhibiting the function of PCSK9, increasing the number of LDL receptors in the liver, and enhancing the uptake and degradation of LDL cholesterol by the liver, thereby lowering LDL cholesterol levels in the blood. These drugs have shown significant efficacy in treating hypercholesterolemia and preventing cardiovascular diseases, particularly for patients who are intolerant to statins or do not respond well to them, providing a new treatment option.

North American market for PCSK9 Cholesterol-Lowering Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for PCSK9 Cholesterol-Lowering Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for PCSK9 Cholesterol-Lowering Drugs in Hyperlipidemia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of PCSK9 Cholesterol-Lowering Drugs include Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences, Jiangsu Hengrui Pharmaceuticals, LEQVIO (Novartis), Verve Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for PCSK9 Cholesterol-Lowering Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCSK9 Cholesterol-Lowering Drugs.

The PCSK9 Cholesterol-Lowering Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PCSK9 Cholesterol-Lowering Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PCSK9 Cholesterol-Lowering Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PCSK9 Cholesterol-Lowering Drugs Market Report

Report Metric	Details
Report Name	PCSK9 Cholesterol-Lowering Drugs Market
Accounted market size in year	US$ 1573 million
Forecasted market size in 2031	US$ 2190 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injection Tablet
Segment by Application	Hyperlipidemia Hypertension Diabetes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences, Jiangsu Hengrui Pharmaceuticals, LEQVIO (Novartis), Verve Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PCSK9 Cholesterol-Lowering Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PCSK9 Cholesterol-Lowering Drugs Market growing?

Ans: The PCSK9 Cholesterol-Lowering Drugs Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the PCSK9 Cholesterol-Lowering Drugs Market size in 2031?

Ans: The PCSK9 Cholesterol-Lowering Drugs Market size in 2031 will be US$ 2190 million.

Who are the main players in the PCSK9 Cholesterol-Lowering Drugs Market report?

Ans: The main players in the PCSK9 Cholesterol-Lowering Drugs Market are Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences, Jiangsu Hengrui Pharmaceuticals, LEQVIO (Novartis), Verve Therapeutics

What are the Application segmentation covered in the PCSK9 Cholesterol-Lowering Drugs Market report?

Ans: The Applications covered in the PCSK9 Cholesterol-Lowering Drugs Market report are Hyperlipidemia, Hypertension, Diabetes, Others

What are the Type segmentation covered in the PCSK9 Cholesterol-Lowering Drugs Market report?

Ans: The Types covered in the PCSK9 Cholesterol-Lowering Drugs Market report are Injection, Tablet

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injection

1.2.3 Tablet

1.3 Market by Application

1.3.1 Global PCSK9 Cholesterol-Lowering Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hyperlipidemia

1.3.3 Hypertension

1.3.4 Diabetes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global PCSK9 Cholesterol-Lowering Drugs Market Perspective (2020-2031)

2.2 Global PCSK9 Cholesterol-Lowering Drugs Growth Trends by Region

2.2.1 Global PCSK9 Cholesterol-Lowering Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 PCSK9 Cholesterol-Lowering Drugs Historic Market Size by Region (2020-2025)

2.2.3 PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Region (2026-2031)

2.3 PCSK9 Cholesterol-Lowering Drugs Market Dynamics

2.3.1 PCSK9 Cholesterol-Lowering Drugs Industry Trends

2.3.2 PCSK9 Cholesterol-Lowering Drugs Market Drivers

2.3.3 PCSK9 Cholesterol-Lowering Drugs Market Challenges

2.3.4 PCSK9 Cholesterol-Lowering Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PCSK9 Cholesterol-Lowering Drugs Players by Revenue

3.1.1 Global Top PCSK9 Cholesterol-Lowering Drugs Players by Revenue (2020-2025)

3.1.2 Global PCSK9 Cholesterol-Lowering Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Top PCSK9 Cholesterol-Lowering Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by PCSK9 Cholesterol-Lowering Drugs Revenue

3.4 Global PCSK9 Cholesterol-Lowering Drugs Market Concentration Ratio

3.4.1 Global PCSK9 Cholesterol-Lowering Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PCSK9 Cholesterol-Lowering Drugs Revenue in 2024

3.5 Global Key Players of PCSK9 Cholesterol-Lowering Drugs Head office and Area Served

3.6 Global Key Players of PCSK9 Cholesterol-Lowering Drugs, Product and Application

3.7 Global Key Players of PCSK9 Cholesterol-Lowering Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 PCSK9 Cholesterol-Lowering Drugs Breakdown Data by Type

4.1 Global PCSK9 Cholesterol-Lowering Drugs Historic Market Size by Type (2020-2025)

4.2 Global PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Type (2026-2031)

5 PCSK9 Cholesterol-Lowering Drugs Breakdown Data by Application

5.1 Global PCSK9 Cholesterol-Lowering Drugs Historic Market Size by Application (2020-2025)

5.2 Global PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America PCSK9 Cholesterol-Lowering Drugs Market Size (2020-2031)

6.2 North America PCSK9 Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

6.4 North America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PCSK9 Cholesterol-Lowering Drugs Market Size (2020-2031)

7.2 Europe PCSK9 Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

7.4 Europe PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size (2020-2031)

8.2 Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PCSK9 Cholesterol-Lowering Drugs Market Size (2020-2031)

9.2 Latin America PCSK9 Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

9.4 Latin America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size (2020-2031)

10.2 Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen PCSK9 Cholesterol-Lowering Drugs Introduction

11.1.4 Amgen Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi PCSK9 Cholesterol-Lowering Drugs Introduction

11.2.4 Sanofi Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Innovent

11.3.1 Innovent Company Details

11.3.2 Innovent Business Overview

11.3.3 Innovent PCSK9 Cholesterol-Lowering Drugs Introduction

11.3.4 Innovent Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.3.5 Innovent Recent Development

11.4 Akesobio

11.4.1 Akesobio Company Details

11.4.2 Akesobio Business Overview

11.4.3 Akesobio PCSK9 Cholesterol-Lowering Drugs Introduction

11.4.4 Akesobio Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.4.5 Akesobio Recent Development

11.5 Junshi Biosciences

11.5.1 Junshi Biosciences Company Details

11.5.2 Junshi Biosciences Business Overview

11.5.3 Junshi Biosciences PCSK9 Cholesterol-Lowering Drugs Introduction

11.5.4 Junshi Biosciences Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.5.5 Junshi Biosciences Recent Development

11.6 Jiangsu Hengrui Pharmaceuticals

11.6.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.6.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.6.3 Jiangsu Hengrui Pharmaceuticals PCSK9 Cholesterol-Lowering Drugs Introduction

11.6.4 Jiangsu Hengrui Pharmaceuticals Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.6.5 Jiangsu Hengrui Pharmaceuticals Recent Development

11.7 LEQVIO (Novartis)

11.7.1 LEQVIO (Novartis) Company Details

11.7.2 LEQVIO (Novartis) Business Overview

11.7.3 LEQVIO (Novartis) PCSK9 Cholesterol-Lowering Drugs Introduction

11.7.4 LEQVIO (Novartis) Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.7.5 LEQVIO (Novartis) Recent Development

11.8 Verve Therapeutics

11.8.1 Verve Therapeutics Company Details

11.8.2 Verve Therapeutics Business Overview

11.8.3 Verve Therapeutics PCSK9 Cholesterol-Lowering Drugs Introduction

11.8.4 Verve Therapeutics Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

11.8.5 Verve Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Jiangsu Hengrui Pharmaceuticals

LEQVIO (Novartis)

Verve Therapeutics

List of Tables

Table 1. Global PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injection

Table 3. Key Players of Tablet

Table 4. Global PCSK9 Cholesterol-Lowering Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global PCSK9 Cholesterol-Lowering Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global PCSK9 Cholesterol-Lowering Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Region (2020-2025)

Table 8. Global PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Region (2026-2031)

Table 10. PCSK9 Cholesterol-Lowering Drugs Market Trends

Table 11. PCSK9 Cholesterol-Lowering Drugs Market Drivers

Table 12. PCSK9 Cholesterol-Lowering Drugs Market Challenges

Table 13. PCSK9 Cholesterol-Lowering Drugs Market Restraints

Table 14. Global PCSK9 Cholesterol-Lowering Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Players (2020-2025)

Table 16. Global Top PCSK9 Cholesterol-Lowering Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCSK9 Cholesterol-Lowering Drugs as of 2024)

Table 17. Ranking of Global Top PCSK9 Cholesterol-Lowering Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by PCSK9 Cholesterol-Lowering Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of PCSK9 Cholesterol-Lowering Drugs, Headquarters and Area Served

Table 20. Global Key Players of PCSK9 Cholesterol-Lowering Drugs, Product and Application

Table 21. Global Key Players of PCSK9 Cholesterol-Lowering Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global PCSK9 Cholesterol-Lowering Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global PCSK9 Cholesterol-Lowering Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global PCSK9 Cholesterol-Lowering Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global PCSK9 Cholesterol-Lowering Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global PCSK9 Cholesterol-Lowering Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global PCSK9 Cholesterol-Lowering Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global PCSK9 Cholesterol-Lowering Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Amgen Company Details

Table 47. Amgen Business Overview

Table 48. Amgen PCSK9 Cholesterol-Lowering Drugs Product

Table 49. Amgen Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 50. Amgen Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi PCSK9 Cholesterol-Lowering Drugs Product

Table 54. Sanofi Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. Innovent Company Details

Table 57. Innovent Business Overview

Table 58. Innovent PCSK9 Cholesterol-Lowering Drugs Product

Table 59. Innovent Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 60. Innovent Recent Development

Table 61. Akesobio Company Details

Table 62. Akesobio Business Overview

Table 63. Akesobio PCSK9 Cholesterol-Lowering Drugs Product

Table 64. Akesobio Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 65. Akesobio Recent Development

Table 66. Junshi Biosciences Company Details

Table 67. Junshi Biosciences Business Overview

Table 68. Junshi Biosciences PCSK9 Cholesterol-Lowering Drugs Product

Table 69. Junshi Biosciences Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 70. Junshi Biosciences Recent Development

Table 71. Jiangsu Hengrui Pharmaceuticals Company Details

Table 72. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 73. Jiangsu Hengrui Pharmaceuticals PCSK9 Cholesterol-Lowering Drugs Product

Table 74. Jiangsu Hengrui Pharmaceuticals Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 75. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 76. LEQVIO (Novartis) Company Details

Table 77. LEQVIO (Novartis) Business Overview

Table 78. LEQVIO (Novartis) PCSK9 Cholesterol-Lowering Drugs Product

Table 79. LEQVIO (Novartis) Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 80. LEQVIO (Novartis) Recent Development

Table 81. Verve Therapeutics Company Details

Table 82. Verve Therapeutics Business Overview

Table 83. Verve Therapeutics PCSK9 Cholesterol-Lowering Drugs Product

Table 84. Verve Therapeutics Revenue in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 85. Verve Therapeutics Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. PCSK9 Cholesterol-Lowering Drugs Picture

Figure 2. Global PCSK9 Cholesterol-Lowering Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Type: 2024 VS 2031

Figure 4. Injection Features

Figure 5. Tablet Features

Figure 6. Global PCSK9 Cholesterol-Lowering Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hyperlipidemia Case Studies

Figure 9. Hypertension Case Studies

Figure 10. Diabetes Case Studies

Figure 11. Others Case Studies

Figure 12. PCSK9 Cholesterol-Lowering Drugs Report Years Considered

Figure 13. Global PCSK9 Cholesterol-Lowering Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global PCSK9 Cholesterol-Lowering Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Players in 2024

Figure 17. Global PCSK9 Cholesterol-Lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by PCSK9 Cholesterol-Lowering Drugs Revenue in 2024

Figure 19. North America PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America PCSK9 Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 21. United States PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe PCSK9 Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 25. Germany PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific PCSK9 Cholesterol-Lowering Drugs Market Share by Region (2020-2031)

Figure 33. China PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America PCSK9 Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 41. Mexico PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa PCSK9 Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 45. Turkey PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE PCSK9 Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Amgen Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 50. Innovent Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 51. Akesobio Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 52. Junshi Biosciences Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 53. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 54. LEQVIO (Novartis) Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 55. Verve Therapeutics Revenue Growth Rate in PCSK9 Cholesterol-Lowering Drugs Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PCSK9 Targeted Drugs Market Research Report 2024

Global Monoclonal Antibodies for Primary Hypercholesterolemia Market Research Report 2024

Global Cholesterol lowering Statins Market Research Report 2024

Global Cholesterol Lowering Biologic Drugs Market Research Report 2024

Global Cholesterol fighting Vaccine Market Research Report 2024

Global Cholesterol Vaccines Market Research Report 2024

Global Nonstatin Cholesterol Medications Market Research Report 2024

Antihyperlipidemic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PCSK9 targeted Therapy Market Research Report 2025

Global Cholesterol Lowering Supplements Market Research Report 2024

Global Blood Lipid Regulating Drugs Market Research Report 2024

Global Anti PCSK9 Monoclonal Antibody Market Insights Forecast to 2030

Global Statins Market Research Report 2024

Global Complex Dyslipidemia Treatment Market Research Report 2025

Global Long Acting Cholesterol Lowering Drugs Market Research Report 2025

Global Cholesterol Absorption Inhibitors Market Research Report 2024

Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ezetimibe Tablets Market Research Report 2024

Global Triglyceride Lowering Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions